Prof. David Adler, MD/PhD, MBA is a senior oncology clinical development and translational medicine leader, whose educational background includes Harvard and Cornell, complemented by executive leadership experience at Bayer AG. Holding professorships at three leading universities in Germany and Israel, he brings extensive clinical research experience and executive leadership to global oncology drug development.